Clinical study on The treatment of senile frailty syndrome by Gulingji Capsule

Guangdong Provincial Hospital of Traditional Chinese Medicine0 个研究点开始时间: 待定最近更新: 2023年2月20日

试验速览

暂无简介。

•1. Aged 65-85 years (including boundary value);
•2. Survival >= 6 months;
•3. It conforms to the indications of senile frailty syndrome, and refers to the definition of frailty standard by Fried et al.;
•4. Those who conform to traditional Chinese medicine kidney-yang deficiency;
•5. No impairment of comprehension, hearing or vision, can perform general commands, can communicate normally and can complete physical assessment tests;
•6. No vestibular or cerebellar dysfunction, can walk independently without assistance;
•7. Patients who signed informed consent after informed consent and volunteered to participate in this study.

•1. Patients with acute or severe malignant chronic diseases in the elderly, such as patients with acute onset of chronic obstructive pulmonary disease, acute coronary syndrome, Parkinson's disease, depression, tuberculosis and malignant tumors;
•2. New York Heart Association (NYHA) grade III to IV;
•3. Patients with severe musculoskeletal diseases;
•4. Those who have taken traditional Chinese medicine for tonifying kidney-yang in the past month or are taking hormones;
•5. Completely bedridden or unable to exercise;
•6. Allergic constitution or allergic to known ingredients of this drug;
•7. Participating in other intervention tests;
•8. The investigator considers it inappropriate to participate in this clinical study.

发起方

Guangdong Provincial Hospital of Traditional Chinese Medicine